• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中 NLRP3 炎性小体的抑制导致癌细胞转移潜能的抑制。

Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells.

机构信息

BK21 PLUS Team, College of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.

出版信息

Sci Rep. 2019 Aug 22;9(1):12277. doi: 10.1038/s41598-019-48794-x.

DOI:10.1038/s41598-019-48794-x
PMID:31439870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6706417/
Abstract

Tumor microenvironment favors tumor cells to promote their growth and metastasis such as migration, invasion, and angiogenesis. IL-1β, one of the inflammatory cytokines released from myeloid cells in tumor microenvironment, plays an important role in development and progress of tumor. The activation of inflammasome is a critical step to secrete mature IL-1β through stepwise reactions to activate capspase-1. Therefore, we investigated whether the inhibition of NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome in macrophages regulated the metastatic potential of tumor cells. NLRP3 inflammasome was activated by ATP in bone marrow-derived primary mouse macrophages. The metastatic potential of mouse melanoma cell line (B16F10) was determined by migration and invasion assays with transwell system. ATP-treated wild-type macrophages increased the migration and invasion of melanoma cells. However, NLRP3- or caspase-1-knockout macrophages exhibited greatly diminished ability to promote the migration and invasion of melanoma cells. In addition, treatment with celastrol, an inhibitor of NLRP3 inflammasome, reduced the potency of macrophages to stimulate migration and invasion of melanoma cells. The results demonstrate that inhibition of the NLRP3 inflammasome in macrophages by genetic deficiency or a pharmacological inhibitor is linked to suppression of the metastatic potential of tumor cells. The results would provide a novel anti-cancer strategy to modulate tumor microenvironment by suppressing NLRP3 inflammasome and consequently reducing IL-1β production.

摘要

肿瘤微环境有利于肿瘤细胞促进其生长和转移,如迁移、侵袭和血管生成。IL-1β是肿瘤微环境中髓系细胞释放的炎症细胞因子之一,在肿瘤的发生和发展中发挥重要作用。炎性小体的激活是通过逐步反应分泌成熟的 IL-1β激活 capspase-1 的关键步骤。因此,我们研究了巨噬细胞中 NACHT、LRR 和 PYD 结构域包含蛋白 3(NLRP3)炎性小体的抑制是否调节肿瘤细胞的转移潜力。ATP 在骨髓来源的原代小鼠巨噬细胞中激活 NLRP3 炎性小体。通过 Transwell 系统的迁移和侵袭实验测定小鼠黑色素瘤细胞系(B16F10)的转移潜力。ATP 处理的野生型巨噬细胞增加了黑色素瘤细胞的迁移和侵袭。然而,NLRP3 或 caspase-1 敲除巨噬细胞表现出极大地减弱促进黑色素瘤细胞迁移和侵袭的能力。此外,用 celastrol(NLRP3 炎性小体的抑制剂)处理可降低巨噬细胞刺激黑色素瘤细胞迁移和侵袭的能力。结果表明,通过遗传缺陷或药理学抑制剂抑制巨噬细胞中的 NLRP3 炎性小体与抑制肿瘤细胞的转移潜力有关。该结果为通过抑制 NLRP3 炎性小体从而减少 IL-1β 产生来调节肿瘤微环境提供了一种新的抗癌策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/cbcbdf0aa9d5/41598_2019_48794_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/2fb531011571/41598_2019_48794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/d2c88b633fcd/41598_2019_48794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/eac630f03af8/41598_2019_48794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/bc297bd663d3/41598_2019_48794_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/e7e3ea536aff/41598_2019_48794_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/6ee3c7ec9165/41598_2019_48794_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/cbcbdf0aa9d5/41598_2019_48794_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/2fb531011571/41598_2019_48794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/d2c88b633fcd/41598_2019_48794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/eac630f03af8/41598_2019_48794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/bc297bd663d3/41598_2019_48794_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/e7e3ea536aff/41598_2019_48794_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/6ee3c7ec9165/41598_2019_48794_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9228/6706417/cbcbdf0aa9d5/41598_2019_48794_Fig7_HTML.jpg

相似文献

1
Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells.肿瘤微环境中 NLRP3 炎性小体的抑制导致癌细胞转移潜能的抑制。
Sci Rep. 2019 Aug 22;9(1):12277. doi: 10.1038/s41598-019-48794-x.
2
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.靶向肿瘤来源的 NLRP3 通过限制 MDSCs 扩增来抑制黑色素瘤进展。
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2000915118.
3
Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome.胸腺醌通过抑制 NLRP3 炎性小体抑制黑素瘤细胞的转移。
Toxicol Appl Pharmacol. 2013 Jul 1;270(1):70-6. doi: 10.1016/j.taap.2013.03.027. Epub 2013 Apr 10.
4
Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.肿瘤细胞来源的外泌体 TRIM59 调控巨噬细胞 NLRP3 炎症小体激活促进肺癌进展。
J Exp Clin Cancer Res. 2020 Aug 31;39(1):176. doi: 10.1186/s13046-020-01688-7.
5
NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.巨噬细胞中的 NLRP3 炎性小体驱动结直肠癌向肝脏转移。
Cancer Lett. 2019 Feb 1;442:21-30. doi: 10.1016/j.canlet.2018.10.030. Epub 2018 Oct 28.
6
Mechanistic Insight Into the Activation of the NLRP3 Inflammasome by in Macrophages.深入了解 NLRP3 炎性小体在巨噬细胞中被 激活的机制。
Front Immunol. 2019 Jul 31;10:1815. doi: 10.3389/fimmu.2019.01815. eCollection 2019.
7
Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.氧化磷脂酰胆碱诱导巨噬细胞中NLRP3炎性小体的激活。
J Leukoc Biol. 2017 Jan;101(1):205-215. doi: 10.1189/jlb.3VMA1215-579RR. Epub 2016 Jun 2.
8
NLRP3 Inflammasome Activation in MΦs-CRC Crosstalk Promotes Colorectal Cancer Metastasis.NLRP3 炎性小体在 MΦs-CRC 串扰中激活促进结直肠癌转移。
Ann Clin Lab Sci. 2022 Jul;52(4):571-579.
9
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.人 NACHT、LRR 和 PYD 结构域包含蛋白 3(NLRP3)炎症小体的活性受布鲁顿酪氨酸激酶调节,并且可能成为其作用靶点。
J Allergy Clin Immunol. 2017 Oct;140(4):1054-1067.e10. doi: 10.1016/j.jaci.2017.01.017. Epub 2017 Feb 16.
10
NLRP3 inflammasome activation in murine macrophages caused by Neospora caninum infection.犬新孢子虫感染引起小鼠巨噬细胞中NLRP3炎性小体激活。
Parasit Vectors. 2017 May 30;10(1):266. doi: 10.1186/s13071-017-2197-2.

引用本文的文献

1
[Avitinib suppresses NLRP3 inflammasome activation and ameliorates septic shock in mice].阿伐替尼抑制小鼠NLRP3炎性小体激活并改善脓毒性休克
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Aug 20;45(8):1697-1705. doi: 10.12122/j.issn.1673-4254.2025.08.14.
2
Targeted degradation of GSPT1 and NEK7 by a molecular glue prodrug for treatment of HCC.一种分子胶前药对GSPT1和NEK7进行靶向降解以治疗肝癌。
Commun Chem. 2025 Aug 14;8(1):247. doi: 10.1038/s42004-025-01641-9.
3
Repurposed clindamycin suppresses pyroptosis in tumor-associated macrophages through Inhibition of caspase-1.

本文引用的文献

1
NLRP3 Inflammasome Modulates Post-Burn Lipolysis and Hepatic Fat Infiltration via Fatty Acid Synthase.NLRP3 炎性小体通过脂肪酸合成酶调节烧伤后脂肪分解和肝脂肪浸润。
Sci Rep. 2018 Oct 12;8(1):15197. doi: 10.1038/s41598-018-33486-9.
2
Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome.甘草查尔酮 A 通过抑制 NLRP3 炎性小体减轻痤疮症状。
Phytother Res. 2018 Dec;32(12):2551-2559. doi: 10.1002/ptr.6195. Epub 2018 Oct 3.
3
Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
重新利用的克林霉素通过抑制半胱天冬酶-1来抑制肿瘤相关巨噬细胞中的细胞焦亡。
J Exp Clin Cancer Res. 2025 Aug 4;44(1):225. doi: 10.1186/s13046-025-03478-5.
4
A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma.一项针对新诊断胶质母细胞瘤患者的生酮饮食加标准治疗的1期安全性和可行性试验。
Sci Rep. 2025 Jul 1;15(1):21064. doi: 10.1038/s41598-025-06675-6.
5
Targeting inflammasomes as an immunotherapeutic strategy for cancer.以炎性小体为靶点作为癌症的免疫治疗策略。
J Transl Med. 2025 Jun 8;23(1):634. doi: 10.1186/s12967-025-06665-2.
6
Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential.炎性小体在癌症免疫中的作用:机制与治疗潜力
J Exp Clin Cancer Res. 2025 Mar 29;44(1):109. doi: 10.1186/s13046-025-03366-y.
7
The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes.肿瘤微环境(TME)在推进癌症治疗中的作用:免疫系统相互作用、肿瘤浸润淋巴细胞(TILs)以及外泌体和炎性小体的作用
Int J Mol Sci. 2025 Mar 18;26(6):2716. doi: 10.3390/ijms26062716.
8
Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It.黑色素瘤中抗PD-1免疫疗法的耐药机制及克服策略
Biomolecules. 2025 Feb 12;15(2):269. doi: 10.3390/biom15020269.
9
Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway.桑色素通过抑制NLRP3/MAPK信号通路对非小细胞肺癌转移的抗炎和抗迁移作用
Biomolecules. 2025 Jan 10;15(1):103. doi: 10.3390/biom15010103.
10
Conventional Chemotherapy and Inflammation: What Is the Role of the Inflammasome in the Tumor Microenvironment?传统化疗与炎症:炎性小体在肿瘤微环境中的作用是什么?
Biomedicines. 2025 Jan 15;13(1):203. doi: 10.3390/biomedicines13010203.
口服萝卜硫素抑制 NLRP3 炎性小体可缓解急性痛风性炎症。
Rheumatology (Oxford). 2018 Apr 1;57(4):727-736. doi: 10.1093/rheumatology/kex499.
4
Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection.细胞外 ATP 激活 NLRP3 炎性小体,是皮肤同种异体移植排斥的早期危险信号。
Cell Rep. 2017 Dec 19;21(12):3414-3426. doi: 10.1016/j.celrep.2017.11.079.
5
BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination.BOT-4-one 可抑制 NLRP3 炎症小体的激活:NLRP3 烷基化导致其 ATP 酶活性和泛素化的调节。
Sci Rep. 2017 Nov 8;7(1):15020. doi: 10.1038/s41598-017-15314-8.
6
Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation.雷公藤红素通过抑制NLRP3炎性小体激活来改善炎症。
Oncotarget. 2017 Jun 27;8(40):67300-67314. doi: 10.18632/oncotarget.18619. eCollection 2017 Sep 15.
7
A new mechanism of inhibition of IL-1β secretion by celastrol through the NLRP3 inflammasome pathway.通过 NLRP3 炎性小体通路,藜芦醇抑制白细胞介素-1β分泌的新机制。
Eur J Pharmacol. 2017 Nov 5;814:240-247. doi: 10.1016/j.ejphar.2017.08.036. Epub 2017 Aug 30.
8
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.姜黄素通过靶向 ASC 在 NLRP3 炎性小体治疗急性痛风中的作用:一种新的治疗策略。
Sci Rep. 2016 Dec 9;6:38622. doi: 10.1038/srep38622.
9
Targeting inflammasome/IL-1 pathways for cancer immunotherapy.针对炎症小体/IL-1 通路的癌症免疫治疗。
Sci Rep. 2016 Oct 27;6:36107. doi: 10.1038/srep36107.
10
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.NLRP3炎性小体的一种药理学抑制剂可预防高脂饮食诱导的小鼠模型中的非酒精性脂肪性肝病。
Sci Rep. 2016 Apr 14;6:24399. doi: 10.1038/srep24399.